Exicure, Inc. - News

2020 2019 2018 2017 2016 2015 2014

12/17/2018

Exicure Announces Top-line Patient Data for Phase 1 Inflammation Program in Psoriasis

11/07/2018

Exicure Announces November 2018 Investor and Scientific Conference Schedule

11/06/2018

Exicure, Inc. Provides Update on Corporate Progress and Third Quarter 2018 Financial Results

10/02/2018

Exicure Presents First Data Demonstrating Both Oral Delivery and Liver Delivery of Spherical Nucleic Acid Constructs in Animal Models

10/01/2018

Data on Exicure’s TLR9 Agonist Spherical Nucleic Acid (SNA™) Construct Presented at the 4th CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

09/28/2018

Exicure, Inc. to Present at Upcoming Investor Conference and Participate in Oncology Roundtable

09/20/2018

Exicure Announces Positive Phase 1 Results for its Lead Immuno-Oncology Asset

08/22/2018

Exicure, Inc. Announces Expected Closing of Approximately $22 Million Private Placement Offering

08/06/2018

Exicure, Inc. Provides Update on Corporate Progress and Second Quarter 2018 Financial Results

06/15/2018

Exicure, Inc. to Present at the 2018 JMP Securities Life Sciences Conference on June 21st at 11:00 a.m. EDT

06/14/2018

Exicure to Present Data at the Cure Spinal Muscular Atrophy Annual Conference in Dallas

06/04/2018

Exicure, Inc. to Present at Jefferies 2018 Healthcare Conference on June 8th at 2:30 p.m. EDT

05/23/2018

Exicure, Inc. To Begin Trading on United States OTCQB® Under the Symbol “XCUR”

05/15/2018

Exicure, Inc. Reports First Quarter 2018 Financial Results and Reviews Corporate Progress

04/30/2018

Exicure Announces Data for Topical Anti-TNF Compound AST-005 in Patients with Mild to Moderate Psoriasis

04/24/2018

Exicure Announces Chief Executive Officer, Dr. David Giljohann, Named to Endpoints News’ “Under-40s” Biopharma Executives List

04/20/2018

Exicure Expands Leadership Team with Appointment of TLR9 Oncology Expert Matthias Schroff as Chief Operating Officer

04/16/2018

Exicure to Present Data at the American Association for Cancer Research (AACR) 2018 Annual Meeting

03/09/2018

Exicure, Inc. Reports Full Year 2017 Financial Results and Corporate Progress

01/31/2018

Exicure to Present at BIO CEO & Investor Conference, Immuno-Oncology 360° Summit and LEERINK Partners 7th Annual Global Healthcare Conference

01/05/2018

Exicure, Inc. to Present at Biotech Showcase 2018